ESTIMATION OF DIRECT AND INDIRECT COSTS ASSOCIATED TO TYPE 2 DIABETES AND ITS COMPLICATIONS MEASURED IN TERTIARY CARE TEACHING HOSPITAL IN KERALA
Akhil Raj
V.Karthikeyan
V.Karthikeyan
Aneeta Varkey
Aneeta Varkey
Madhavadas Joy
Madhavadas Joy
Kiran DR
Kiran DR
Diabetes mellitus (DM) is one of the most burdensome chronic diseases and is associated with shorter lifetime, diminished quality of life and economic burdens on the patient and society as a result of healthcare, medication, and reduced labor market participation. We aimed to estimate the direct (medical and non-medical) and indirect costs of DM and compare them with those of people without DM, as well as the cost predictors. To estimate direct and indirect costs of care of type 2 diabetes (T2DM) and its complications associated with diabetes mellitus patients in Kerala. A prospective drug utilization study was conducted in Type 2 diabetes mellitus patients in the department of General Medicine and Surgery at Karuna Medical College Hospital (KMCH), Kerala for 6 months - between from November 2017 to April 2018. The direct medical cost includes the medication costs, cost of laboratory investigations, cost of consultation and cost of hospitalization and the direct non-medical costs include the transportation cost to hospital and cost of food during the hospitalization. The indirect costs (i.e., productivity loss) were determined based on modified labor force, employment and earnings data based on job category for patients who were employed during the evaluation period. As indicated in Table 23, the total cost of illness of diabetes was estimated to 299497.6 Rupees for 6 months, of which 93.26% was direct medical cost and 6.68% was direct non-medical costs. Drugs took lion’s share of direct medical cost 85.07%. Healthcare use and costs were dramatically higher for people with DM than for people with normal glucose tolerance and, in relative terms, much higher than in developing and developed countries.
8 , 1 , 2018
8 - 12
Subscriber Login
